House and Senate Pass Mental Health Parity Extension
Client Alert | less than 1 min read | 12.22.03
The House and Senate have each passed bills that would extend the applicability of the Mental Health Parity Act of 1996 ("MHPA") an additional year. The Senate version, S. 1929, passed by unanimous consent. MHPA, the provisions of which appear in Section 702 of ERISA, was scheduled to expire as of December 31, 2003. MHPA requires group health plans to provide annual and lifetime limits on mental health benefits that are identical to those provided by the plan for major medical benefits. Small employers-generally those with 50 or fewer employees-are exempt from MHPA's requirements.
Insights
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development
Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage.
Client Alert | 6 min read | 09.14.26
Mental Health Parity Bulletin Restates Best Practices for Evaluating Compliance
Client Alert | 6 min read | 09.11.26
It’s LIVE: The Cyber Resilience Act Reporting Is Mandatory as of Today - 11 September 2026
Client Alert | 10 min read | 09.11.26
Mining, Indigenous Consultation Rights, and Investment Treaty Protection
